PureTech Health Company Top Insiders
| PTCHF Stock | USD 1.71 0.01 0.59% |
PureTech Health employs about 95 people. The company is managed by 10 executives with a total tenure of roughly 10 years, averaging almost 1.0 years of service per executive, having 9.5 employees per reported executive. Examination of PureTech Health's management performance can provide insight into the company performance.
| Daphne Zohar CEO Co-Founder, CEO and Executive Director |
| Eric Elenko President Executive Vice President - Science & Technology |
PureTech |
PureTech Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.1333) % which means that it has lost $0.1333 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0152) %, meaning that it generated substantial loss on money invested by shareholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities.PureTech Health owns a total of 278.81 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as PureTech Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of PureTech Health, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
PureTech Health Workforce Comparison
PureTech Health plc is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 244. PureTech Health totals roughly 95.0 in number of employees claiming about 39% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (0.73) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (9.87) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $9.87. PureTech Health plc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. PureTech Health plc Price Series Summation is a cross summation of PureTech Health price series and its benchmark/peer.
PureTech Health Notable Stakeholders
A PureTech Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PureTech Health often face trade-offs trying to please all of them. PureTech Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PureTech Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| David Elmaleh | Co-Founder and Sr. Advisor | Profile | |
| Daphne Zohar | Co-Founder, CEO and Executive Director | Profile | |
| Eric Elenko | Executive Vice President - Science & Technology | Profile | |
| Spencer Ball | Vice President - Talent Acquisition | Profile | |
| Bennett MD | Co-Founder and Non-Executive Director | Profile | |
| Allison Talbot | Head Relations | Profile | |
| Joseph Bolen | Chief Scientific Officer | Profile | |
| Aleksandra MD | Head Oncology | Profile | |
| Dr JD | Sec and President | Profile |
About PureTech Health Management Performance
The success or failure of an entity such as PureTech Health plc often depends on how effective the management is. PureTech Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PureTech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PureTech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 95 people.
PureTech Health Workforce Analysis
Traditionally, organizations such as PureTech Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PureTech Health within its industry.PureTech Health Manpower Efficiency
Return on PureTech Health Manpower
| Revenue Per Employee | 105K | |
| Revenue Per Executive | 997.9K | |
| Net Loss Per Employee | 637.5K | |
| Net Loss Per Executive | 6.1M |
Complementary Tools for PureTech Pink Sheet analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |